What is PROF (PROF) stock price today?

PROF (PROF) is currently trading at $7.25, down 1.09% today.

What is PROF P/E ratio?

PROF's P/E ratio is -8.98. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is PROF return on equity (ROE)?

PROF's return on equity (ROE) is -70.59%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is PROF's market cap?

PROF has a market capitalization of $263.45M.

NASDAQ · Medical - Devices

PROF (PROF) Stock

$7.25 -1.09% NASDAQ: PROF Healthcare

Valuation

Metric	Value
Price	$7.25
Market Cap	$263.45M
P/E Ratio	-8.98
P/B Ratio	4.13
P/S Ratio	10.89
EPS (TTM)	$-0.78
52-Week High	$8.95
52-Week Low	$3.76
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-70.59%
ROA	-35.47%
ROCE	-46.15%
Gross Margin	71.04%
Operating Margin	-2.03%
Net Margin	-2.07%
Debt/Equity	0.13
Current Ratio	13.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$7.0M	$7.0M	$7.0M	$10.0M	$16.0M
Operating Profit	$-30.0M	$-32.0M	$-29.0M	$-31.0M	$-42.0M
Net Profit	$-31.0M	$-29.0M	$-29.0M	$-26.0M	$-43.0M
EPS	$-1.50	$-1.38	$-1.35	$-1.07	$-1.43
Op Margin	-440.7%	-480.9%	-397.5%	-309.6%	-256.3%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$87.0M	$64.0M	$44.0M	$70.0M	$193.0M
Total Liabilities	$6.0M	$12.0M	$13.0M	$10.0M	$102.0M
Cash	$67.0M	$47.0M	$26.0M	$55.0M	$82.0M
Borrowings	$1.0M	$8.0M	$8.0M	$5.0M	$6.0M

Latest News

Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow GlobeNewswire · Jul 16, 2026 Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026 GlobeNewswire · Jul 15, 2026 Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last? Zacks · Jul 7, 2026 Profound Medical Corp. (PROF) Dropped Despite High Potential Insider Monkey · Jun 22, 2026 Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High? Zacks · May 18, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-22.0M	$-26.0M	$-23.0M	$-23.0M	$-53.0M
Investing Cash Flow	$-1.0M	$0	$0	$0	$-1.0M
Financing Cash Flow	$6.0M	$0	$3.0M	$-5.0M	$-1.0M
Net Cash Flow	$-17.0M	$-21.0M	$-20.0M	$29.0M	$6.0M
Free Cash Flow	$-23.0M	$-26.0M	$-23.0M	$-23.0M	$-54.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	-5.26
FCF Yield	-18.85%
Quick Ratio	5.71
Interest Coverage	—
Return 1Y	17.50%
Return 3Y	-43.85%
Return 5Y	-56.17%

Ownership

Insiders Held4.07%

Institutions Held44.63%

Institutions Float Held46.52%

Institutional Holder	Shares	Report Date
FIL LTD	2,340,000	2026-03-31
Gagnon Securities, LLC	1,944,324	2026-03-31
Royce & Associates LP	1,116,348	2026-03-31
Timelo Investment Management Inc.	1,114,967	2026-03-31
Gagnon Advisors, LLC	962,186	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ARMPArmata Pharmaceuticals, Inc.	$4.64	-0.43%	-0.60	$170.34M	0.00%
AVR	$8.28	+0.00%	-2.56	$304.61M	0.00%
CATX	$3.00	+1.01%	-2.59	$342.14M	0.00%
LNSR	$5.25	-1.87%	6.53	$63.55M	0.00%
MXCT	$1.18	+6.31%	-2.55	$126.40M	0.00%

About PROF

PROF is led by CEO Arun Swarup Menawat, employs 142 people, headquartered in CA, publicly traded since 2019.

PROF stock trades at $7.25 with a market capitalization of $263.45M. The stock is valued at a price-to-earnings (P/E) ratio of -8.98, price-to-book of 4.13, price-to-sales of 10.89. Over the past 52 weeks the stock has ranged between $3.76 and $8.95, and currently trades 19.0% below its 52-week high.

On profitability, PROF generates a return on equity (ROE) of -70.59%, return on capital employed of -46.15%, an operating margin of -2.03%, a net profit margin of -2.07%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides